Literature DB >> 2823586

Percutaneous ethanol injection in the treatment of liver neoplasms.

S Shiina1, H Yasuda, H Muto, K Tagawa, T Unuma, K Ibukuro, Y Inoue, R Takanashi.   

Abstract

The effectiveness of percutaneous ethanol injection therapy was investigated in 30 patients who had hepatocellular carcinoma (18 had a single lesion and 12 had multiple lesions). In patients who had a single lesion, ethanol injection was especially effective. Histopathologic examination, performed in nine cases in this group, showed that the tumor was completely necrotic in six cases, 90% necrotic in two cases, and 70% necrotic in the remaining case. In eight other cases with a single tumor, follow-up angiography showed complete disappearance of the tumor stain. In the other case, CT showed the nonenhanced low-density area. In the 12 patients with multiple lesions, ethanol injection was performed as part of an integrated treatment plan. Eleven were still alive at the end of the study (the mean follow-up period was 5.8 months). We conclude that ethanol injection may be a valuable treatment for hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823586     DOI: 10.2214/ajr.149.5.949

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  32 in total

1.  Hepatocellular carcinoma.

Authors:  T Ezaki
Journal:  BMJ       Date:  1992-01-25

Review 2.  Ethanol injection for the treatment of hepatic tumours.

Authors:  C Bartolozzi; R Lencioni
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

3.  Multiple-needle insertion method in percutaneous ethanol injection therapy for liver neoplasms.

Authors:  S Shiina; Y Hata; Y Niwa; Y Komatsu; T Tanaka; K Yoshiura; E Hamada; M Ohshima; H Mutoh; M Kurita
Journal:  Gastroenterol Jpn       Date:  1991-02

Review 4.  Image-guided percutaneous ablation therapies for hepatocellular carcinoma.

Authors:  Shuichiro Shiina
Journal:  J Gastroenterol       Date:  2009-01-16       Impact factor: 7.527

5.  Splenic ablation by percutaneous injection of ethanolamine oleate in dogs: a possible therapy for hypersplenism.

Authors:  S Shiina; H Aoyama; Y Shiratori; Y Hata; Y Niwa; Y Komatsu; H Mutoh; M Kurita; R Nakata; T Shimada
Journal:  Gastroenterol Jpn       Date:  1989-12

Review 6.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

7.  Comparison of the proliferative capacity of adenomatous hyperplasia and well differentiated hepatocellular carcinoma.

Authors:  A Yamashita
Journal:  J Gastroenterol       Date:  1996-06       Impact factor: 7.527

8.  Advances and Future Directions in the Treatment of Hepatocellular Carcinoma.

Authors:  Ashil J Gosalia; Paul Martin; Patricia D Jones
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-07

9.  Long-term results of percutaneous ethanol injection for the treatment of hepatocellular carcinoma in Korea.

Authors:  Yon Mi Sung; Dongil Choi; Hyo K Lim; Won Jae Lee; Seung Hoon Kim; Min Ju Kim; Seung Woon Paik; Byung Chul Yoo; Kwang Cheol Koh; Joon Hyoek Lee; Moon Seok Choi
Journal:  Korean J Radiol       Date:  2006 Jul-Sep       Impact factor: 3.500

10.  Efficacy of combination treatment--(TAE with adriamycin and ethanol)--for hepatocellular carcinoma.

Authors:  Y Hasuike; J Okamura; J Furukawa; M Naoi; N Takata; H Maruyama; M Kinuta; E Yayoi; H Oi; S Okamoto
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.